ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+12.94% - 44,934 M€
+19.13% - 35,761 M€
+9.15% - 28 M€
+5.52% - 33 M€
+14.87% - 33 M€
+5.72% - 37 M€
+0.45% - 49 M€
+12.09% - 66 M€
+9.73% - 67 M€
+9.76% - 75 M€
+5.72% - 80 M€
+13.92% - 122 M€
+1.96% - 293 M€
+11.20% - 27,154 M€
+18.13% - 750 M€
+13.56% - 507 M€
+4.28% - 165 M€
+18.96% - 148 M€
+35.64%9.51% 15 M€
+33.63%9.43% 429 M€
+26.39%9.05% 78 M€
+26.87%9.05% 1,079 M€
+28.01%8.88% 9,953 M€
+26.11%8.54% 81 M€
+22.68%4.47% 7 M€
+15.01%4.4% 28 M€
+36.59%4.33% 11 M€
+64.23%4.15% 58 M€
+51.37%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated